Search clinical trials for: LPCN 1021

Total 1613 results

Lipocine Inc.

Completed

A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia

Liver Cirrhosis | Sarcopenia

United States
Lipocine Inc.

Active, not recruiting

A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial

NASH - Nonalcoholic Steatohepatitis

United States
Autotelicbio

Recruiting

Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes

Diabetes Mellitus, Type 2 | Essential Hypertension

Korea, Republic of
Autotelicbio

Completed

Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012

Healthy Adult Volunteers

Korea, Republic of
Centre for Probe Development and Commercialization

Completed

A Safety and Biodistribution Study of [I-124]-CPD-1028 Injection in Solid Tumours

Cancer

Canada
Lipocine Inc.

Completed

Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021) (DF)

Hypogonadism, Male
Lipocine Inc.

Completed

Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021). (DV)

Hypogonadism, Male
Lipocine Inc.

Completed

Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men

Hypogonadism, Male

United States
Apollomics Inc.

Recruiting

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)

Gastric Cancer | Pancreatic Cancer | NSCLC | Lung Cancer | Brain Tumor | Glioblastoma Multiforme | Advanced Cancer | Colon Cancer | Solid Tumors | Thyroid Cancer | Renal Cancer | Gastroesophageal Junction Adenocarcinoma | EGFR Gene Mutation | MET Amplification | HGF | MET Alteration | MET Fusion | Exon 14 Skipping

United States, Spain, France, United Kingdom, Taiwan, Australia, Finland, Italy, Singapore, Hungary, Canada, Puerto Rico, Russian Federation
BioLineRx, Ltd.

Terminated

A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021

Healthy | Volunteers

Israel
Brainvectis, a subsidiary of Asklepios BioPharmaceutical...

Active, not recruiting

A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease

Huntington Disease

France
Lipocine Inc.
PPD; Syneos Health

Completed

Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism (SOAR)

Male Hypogonadism
PhotonMD, Inc

Completed

Modulated Light Therapy in Participants With Pattern Hair Loss

Androgenetic Alopecia

Australia
Assiut University

Not yet recruiting

Pericapsular Nerve Group Block vs Supra Inguinal Fascia Iliaca Compartment Block

Pain, Postoperative
Apollomics Inc.

Recruiting

A Study Comparing Two Different Capsules, APL-101 and PLB-1001 Capsules, in Healthy Chinese and Caucasian Participants

Bioequivalence

New Zealand
Derince Training and Research Hospital
Bursa Yüksek İhtisas Education and Research Hospital

Completed

Comparison of the Efficacy of PENG Block in Combination With LFCN Block and Wound Infiltration

Postoperative Pain

Turkey
Zonguldak Bulent Ecevit University

Active, not recruiting

'The Effect of Adding LFCN Block to PENG

Pain, Postoperative | Pain, Acute | Nerve Block | Opioid Consumption

Turkey
Konya Necmettin Erbakan Üniversitesi

Completed

Comparison of Pericapsular Nerve Group Block and Quadratus Lumborum Block

Total Hip Surgery | Pericapsular Nerve | Quadratus Lumborum

Turkey
Shanghai Mental Health Center
Shanghai Jiao Tong University School of Medicine

Unknown

Modulation of Repetitive Transcranial Magnetic Stimulation on Hippocampal Neurogenesis and Functional Network in Patients With Schizophrenia

Schizophrenia

China
Lukas J Hefermehl
Kantonsspital Baden

Recruiting

Comparing Two Different Approaches in Robotic-Assisted Renal Surgery (PIONEER-OPT)

Renal Tumor

Switzerland
Neurovance, Inc.

Completed

A Study to Evaluate the Safety, Tolerance, and Pharmacokinetic and Pharmacodynamic Profile Of 1 SR Formulation of EB-1020

Normal, Healthy Volunteers

Australia
Lipocine Inc.

Completed

The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic Steatohepatitis (NASH)

United States
Palo Alto Veterans Institute for Research
National Institute on Aging (NIA)

Completed

Noninvasive Brain Stimulation for Mild Cognitive Impairment

Cognitive Dysfunction | Mild Cognitive Impairment | Cognitive Decline | Memory Impairment | Memory Loss | Mild Neurocognitive Disorder | Mental Deterioration | Memory Decline

United States
Daacro
DuPont Nutrition and Health

Completed

Stress & Anxiety Dampening Effects of a Probiotic Supplement Compared to Placebo in Healthy Subjects

Healthy | Stress, Psychological

Germany
Duramed Research

Completed

Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive

Contraception

United States
Mansoura University

Unknown

Which Analgesia is Better for Proximal Femoral Fractures?

Proximal Femur Fracture

Egypt
Nguyen Thi Trieu, MD

Completed

Composition for Treating Cirrhosis and Liver Cancer (SB-1121) (SB-1121)

Cirrhosis of the Liver

Vietnam
Merck Sharp & Dohme LLC

Completed

A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003)

Asthma
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma

Asthma

United States, Australia, New Zealand, South Africa
Alcon Research

Recruiting

Contralateral Study of WaveLight® Femtosecond Laser Devices for Corneal Flap Creation

Refractive Errors

Australia
Northumbria University
DuPont Nutrition and Health

Completed

The Cognitive Effects of 6 Weeks Administration With a Probiotic

Cognitive Change

United Kingdom
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Recruiting

SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations

Non-small Cell Lung Cancer

China
Vanderbilt University Medical Center

Withdrawn

Penicillin Allergy Risk-Stratification and Delabeling of Low-Risk Patients

Antibiotic Allergy

United States
Ruijin Hospital
Regend Therapeutics

Not yet recruiting

Follow-up Study of Autologous Transplantation of P63+ Lung Progenitor Cells for Treatment of Bronchiectasis

Bronchiectasis

China
NuCana plc

Terminated

NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer

Ovarian Cancer

United States, United Kingdom
University of Chicago
Asphelia Pharmaceuticals

Completed

Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)

Allergic Rhinitis

United States
Baylor College of Medicine
Center for Cell and Gene Therapy, Baylor College of Medicine

Active, not recruiting

A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells (CHESAT)

Neuroblastoma

United States
Allegro Ophthalmics, LLC

Completed

A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration

Macular Degeneration

Mexico
Aprea Therapeutics

Not yet recruiting

Study of APR-1051 in Patients With Advanced Solid Tumors

Advanced Solid Tumor
TYK Medicines, Inc

Recruiting

A Study of TY-1091 in Patients With Advanced Solid Tumors

Neoplasms | Medullary Thyroid Cancer | RET-altered Non Small Cell Lung Cancer | RET-altered Papillary Thyroid Cancer

China
Parasail, LLC

Available

Intravenous VAL-1221 Lafora Expanded Access Protocol (LEAP)

Lafora Disease
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

PhaseⅠStudy of the HS-10241 in Patients With Advanced Solid Tumors

Solid Tumor

China
Melior Pharmaceuticals
Bukwang Pharmaceutical, Co., Ltd.

Completed

Adult Subjects With Uncontrolled Type 2 Diabetes

Type 2 Diabetes

United States
VGX Pharmaceuticals, LLC
GeneOne Life Science, Inc.

Completed

Multiple-Dose Study of VGX-1027 in Healthy Subjects

Healthy

United States
Welichem Biotech Inc.

Completed

Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis (WBI-1001-201)

Dermatitis, Atopic

Canada
Dalhousie University
Canadian Institutes of Health Research (CIHR); NewLink Genetics Corporation

Completed

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (VSVΔG-ZEBOV)

Ebola Viruses
Bristol-Myers Squibb
Cardioxyl Pharmaceuticals, Inc

Completed

Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure

Heart Failure

United States
Neothetics, Inc

Completed

A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity

Weight

United States
Mersana Therapeutics

Completed

A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors

Small Cell Lung Cancer | Non-small Cell Lung Cancer

United States
M.D. Anderson Cancer Center
Blue Earth Therapeutics

Recruiting

NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial

Prostate Cancer

United States

Search clinical trials for: LPCN 1021

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations